<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/4.3.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" version="4.3.6" xsi:schemaLocation="http://www.crossref.org/schema/4.3.6 https://www.crossref.org/schemas/crossref4.3.6.xsd">
  <head>
    <doi_batch_id>_1638003546</doi_batch_id>
    <timestamp>1638003546</timestamp>
    <depositor>
      <depositor_name>brea</depositor_name>
      <email_address>akaviani@archbreastcancer.com</email_address>
    </depositor>
    <registrant>Farname Inc</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata>
        <full_title>Archives of Breast Cancer</full_title>
        <abbrev_title>Arch Breast Cancer</abbrev_title>
        <issn media_type="electronic">2383-0433</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="online">
          <month>10</month>
          <day>31</day>
          <year>2021</year>
        </publication_date>
      </journal_issue>
      <journal_article xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" publication_type="full_text" metadata_distribution_opts="any">
        <titles>
          <title>Spindle Cell Carcinoma of the Breast: A Case Report Representing Diagnostics, Therapeutics, Intervention, and Outcome</title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first" language="en">
            <given_name>Mohammad </given_name>
            <surname>Naser Athamnah</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Shatha </given_name>
            <surname>M. Al-Barrak</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Nimah </given_name>
            <surname>A. Rabai</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Tea </given_name>
            <surname>Natelauri</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Hussein </given_name>
            <surname>S O Al Azzam</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Mohammed </given_name>
            <surname>Alorjani</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Omar </given_name>
            <surname>M. Al-Rusan</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional" language="en">
            <given_name>Amer</given_name>
            <surname>Abu-Shanab</surname>
          </person_name>
        </contributors>
        <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1">
          <jats:p>Background: Spindle cell carcinoma (SpCC) is an unusual form of squamous cell carcinoma (SCC) and can sometimes present in the breast. Owing to the rarity of breast SpCC, few case studies are available nowadays and proper evidence is scarce. 
Case presentation: We herein report a 60-year-old female patient, who was referred to the surgery services after presenting with a right breast ulcerated mass. On physical examination, a 7x7 cm mass was found along with a 3 cm ulcer on the top of it. Both mammography and ultrasound showed a dense mass, and tru-cut and skin punch biopsies confirmed neoplastic spindle cells within the lesion. The patient underwent a right total mastectomy with sentinel lymph node biopsies with no further chemotherapy or radiotherapy.
Conclusion: Owing to the heterogeneity of SpCC, there is no exact treatment protocol for this type of cancer, and mastectomy or conservative surgery can be performed in certain groups of patients depending on tumor size, stage, and lymph node involvement. Fortunately, promising medical and biological therapies might be of use in the near future.</jats:p>
        </jats:abstract>
        <publication_date media_type="online">
          <month>10</month>
          <day>31</day>
          <year>2021</year>
        </publication_date>
        <pages>
          <first_page>350</first_page>
          <last_page>357</last_page>
        </pages>
        <ai:program xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" name="AccessIndicators">
          <ai:license_ref>http://creativecommons.org/licenses/by-nc/4.0</ai:license_ref>
        </ai:program>
        <doi_data>
          <doi>10.32768/abc.202184350-357</doi>
          <resource>https://www.archbreastcancer.com/index.php/abc/article/view/430</resource>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>https://www.archbreastcancer.com/index.php/abc/article/download/430/577</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">https://www.archbreastcancer.com/index.php/abc/article/download/430/577</resource>
            </item>
          </collection>
        </doi_data>
      </journal_article>
    </journal>
  </body>
</doi_batch>
